- Home
- VRAR vs PYPD Comparison
VRAR vs PYPD Comparison
Compare VRAR & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAR
- PYPD
- Stock Information
- Founded
- VRAR 2016
- PYPD 2008
- Country
- VRAR United States
- PYPD Israel
- Employees
- VRAR N/A
- PYPD N/A
- Industry
- VRAR Retail: Computer Software & Peripheral Equipment
- PYPD Medical/Dental Instruments
- Sector
- VRAR Technology
- PYPD Health Care
- Exchange
- VRAR Nasdaq
- PYPD Nasdaq
- Market Cap
- VRAR 33.3M
- PYPD 36.0M
- IPO Year
- VRAR 2021
- PYPD 2020
- Fundamental
- Price
- VRAR $1.49
- PYPD $3.40
- Analyst Decision
- VRAR Strong Buy
- PYPD Strong Buy
- Analyst Count
- VRAR 1
- PYPD 5
- Target Price
- VRAR $2.62
- PYPD $11.40
- AVG Volume (30 Days)
- VRAR 135.2K
- PYPD 215.1K
- Earning Date
- VRAR 05-15-2025
- PYPD 08-13-2025
- Dividend Yield
- VRAR N/A
- PYPD N/A
- EPS Growth
- VRAR N/A
- PYPD N/A
- EPS
- VRAR N/A
- PYPD N/A
- Revenue
- VRAR $8,756,789.00
- PYPD N/A
- Revenue This Year
- VRAR $23.96
- PYPD N/A
- Revenue Next Year
- VRAR $12.15
- PYPD N/A
- P/E Ratio
- VRAR N/A
- PYPD N/A
- Revenue Growth
- VRAR N/A
- PYPD N/A
- 52 Week Low
- VRAR $0.50
- PYPD $2.30
- 52 Week High
- VRAR $7.00
- PYPD $4.42
- Technical
- Relative Strength Index (RSI)
- VRAR 52.95
- PYPD 51.00
- Support Level
- VRAR $1.31
- PYPD $3.34
- Resistance Level
- VRAR $1.38
- PYPD $3.53
- Average True Range (ATR)
- VRAR 0.11
- PYPD 0.15
- MACD
- VRAR 0.01
- PYPD -0.04
- Stochastic Oscillator
- VRAR 66.67
- PYPD 14.68
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.